
At ScreeNingBio
ScreeningBio is a preclinical biology Contract Research Organization (CRO) focused on enabling efficient and reliable early drug discovery.
We support biotech and pharmaceutical companies across the discovery lifecycle—from target validation and assay development to compound screening and lead profiling. Our services are designed to generate actionable biological data that helps clients move programs forward with confidence.
By combining experienced scientific teams, scalable in-vitro platforms, and flexible project execution, ScreeningBio serves as a practical and dependable partner for preclinical biology outsourcing.
Why ScreeNingBio
Drug discovery decisions depend on biology that is robust, reproducible, and delivered on time. ScreeningBio was built to meet these expectations.
-
Discovery-focused execution
We understand the pace and uncertainty of early drug discovery and design projects to support fast, informed decision-making. -
Flexible collaboration model
From standalone assays to long-term screening programs, we adapt to each client’s scientific goals, timelines, and budgets. -
Clear communication & transparency
Dedicated project management, regular updates, and clear data reporting—no black boxes. -
Reliable CRO operations
Standardized workflows, validated assays, and quality-controlled data ensure consistency across studies.
Our Strengths
What sets ScreeningBio apart as a preclinical biology CRO
-
Cell-Based Biology Expertise
Strong capabilities in cell line generation, functional assays, pathway signaling, and target engagement studies. -
Assay Development for Screening
Assays are built not just to “work,” but to be screen-ready, scalable, and reproducible. -
Compound Screening & Profiling
Medium- to high-throughput screening, concentration–response analysis, and comparative profiling to support hit-to-lead and lead optimization. -
Business-Aligned Delivery
We focus on decision-enabling data, realistic timelines, and practical recommendations—biology that supports program progression



